Comment on:Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis

Autor: Zhihong Xu, Tony C. Y. Pang, Adele C. Liu, Srinivasa P. Pothula, Alpha Raj Mekapogu, Chamini J. Perera, Takashi Murakami, David Goldstein, Romano C. Pirola, Jeremy S. Wilson, Minoti V. Apte

Publikováno v: Che, PP, Gregori, A, Peters, G J, Dahele, M, Sminia, P & Giovannetti, E 2020, ' Comment on : Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis ', British Journal of Cancer, vol. 123, no. 9, pp. 1464-1465 . https://doi.org/10.1038/s41416-020-1003-7, https://doi.org/10.1038/s41416-020-1003-7
British Journal of Cancer
British Journal of Cancer, 123(9), 1464-1465. Nature Publishing Group

Background Stromal–tumour interactions facilitate pancreatic cancer (PC) progression. The hepatocyte growth factor (HGF)/c-MET pathway is upregulated in PC and mediates the interaction between cancer cells and stromal pancreatic stellate cells (PSC

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1ef688e644eba998e41a33da973b599
https://research.vumc.nl/en/publications/214210eb-7786-4a77-8cd0-c7aadcc7b5ba